Healx, an AI-powered, patient-inspired, biotech company based in Cambridge (UK), is seeking drug redevelopment opportunities from academics, clinicians or recent university spinouts in the area of Rare Disease. Healx will collaborate with the asset holders to quickly turn their research into approved treatments that benefit the rare disease community.
Approaches of Interest
- Open to rare or orphan diseases (prevalence <5/10,000) with current unmet medical needs, with a particular interest in rare renal, inflammatory, neuromuscular, bone and ocular conditions...